Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02563 BIOSTAR PHARM-B
RT Nominal down3.720 -0.010 (-0.268%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others141,650-2.810%145,745163,725122,710102,902
Land & other Lease Assets1,572-26.726%2,1451,34813,47714,862
Intangible Assets12,199-1.999%12,44812,9601,6272,832
Interests in Asso. & JCEs0--0000
Other Non-current Assets35,862-0.104%35,89935,9521,0001,072

191,283-2.525%196,237213,985138,814121,668
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories48,0255.565%45,49431,41927,26731,109
Trade Receivables20,840191.207%7,15723,15211,15934,620
Cash & Bank Balances470,4082.986%456,767466,63638,08760,106
Other Current Assets10,433-84.795%68,615178,052557,017678,835
Assets Held for Sale0--0000

549,707-4.900%578,032699,259633,530804,670
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables52,431-2.585%53,82348,33124,44020,099
S-T Debt & Leases0--007321,091
Other Current Liabilities10,259-34.182%15,58730,83018,57130,535
Liab asso w/ Assets Held for Sale0--0000

62,690-9.681%69,40979,16143,74351,725
Net Current Assets487,017-4.248%508,623620,098589,787752,945
Total Assets Less Current Liabilities678,300-3.768%704,860834,083728,601874,613
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases606-34.693%927517167813
Other Non-current Liabilities37,825-0.077%37,85442,8195,2735,875

38,431-0.904%38,78143,3365,4406,688
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital364,5880.000%364,588364,588350,000350,000
  Reserves275,281-8.693%301,490426,160373,161517,925
  Others0--0000
Shareholders' Funds639,869-3.935%666,078790,748723,161867,925
Non-controlling Interests0--0000
Others0--0000

639,869-3.935%666,078790,748723,161867,925
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments--------108,402136,242
Contingent Liabilities--------00
Remarks:  Real time quote last updated: 04/09/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -26,596
%Change-50.787%
EPS / (LPS)RMB -0.070
NBV Per Share (¥)RMB 1.755
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.